Rectal cancer; Preoperative chemoradiotherapy; Microvessel density; Local recurrence.
直肠癌；术前放化疗；微血管密度；局部复发。
The effects in chemoradiotherapy and radiotherapy groups were better than inchemoptherapy group.
放化疗组和放疗组疗效好于化疗组，放化疗组略好于放疗组。
After chemoradiotherapy, 14 subjects exhibited PR, while 13 showed SD. None of the subjects showed PD.
在化疗后，14名患者显示为PR,13名患者显示为SD，没有一名患者出现PD。
Worse body image was associated with the presence of stoma (P < . 001) and chemoradiotherapy (P < . 05).
较差的身体外在表现与存在吻合口（P<0.001）和放化疗（P<0.05）有关。
Objective to investigate the significance of pancreatic cancer cells resistance to chemoradiotherapy induces EMT.
目的探讨对放、化疗抵抗的胰腺癌细胞发生上皮间质转化(EMT)的意义。
Immunotherapy has drawn more and more attention from medicine following up surgery and chemoradiotherapy of tumor.
继手术、化疗、放疗之后免疫治疗越来越受到医学界的重视。
Objective: To study the clinical effect of concurrent chemoradiotherapy in patients with inoperable esophageal cancer.
目的：不能手术的食管癌同步放化疗的疗效观察。
TCM treatment can completely uprooted chemoradiotherapy residue after the cancer cells, prevent recurrence diffusion transfer again.
中医治疗能彻底铲除化放疗后残留的癌细胞，预防复发扩散再转移。
Objective to assay the efficacy and toxicities of preoperative chemoradiotherapy in treatment of patients with local advanced rectal cancer.
目的评价局部晚期直肠癌术前放化疗的效果及毒副作用。
Objective To investigate the clinical curative effects and side effects of chemoradiotherapy for medium-term and advanced cervical carcinoma.
目的观察化疗联合放疗治疗中晚期宫颈癌的临床疗效和毒副作用。
So the higher DWI volumetric tumor reduction rate is more inclined to have negative nodes in rectal cancer with preoperative chemoradiotherapy.
直肠癌术前放化疗过程的不同时间点体积变化无法准确提示肿瘤是否降期。
More recently, the emergence of neo-adjuvant chemoradiotherapy has fundamentally changed the management of patients with locally advanced disease.
最近，新辅助放化疗的出现已经根本改变了限局型浸润型结肠癌患者的治疗方式。
Chemoradiotherapy did not improve survival, as median survival was 15.5 months in 175 patients who received it and 16.1 months in 178 patients who did not.
化放疗组没有改善存活时间，175名接受该疗法的患者平均存活时间为15.5个月，178名未接受该疗法的患者平均存活时间为16.1个月。
Objective To explore the protective effect of L-Ornithine-L-Aspartate(LOLA) assisted with chemoradiotherapy in patient of lymphoma with hepatitis B virus(HBV).
目的探讨门冬氨酸鸟氨酸在乙肝病毒感染的恶性淋巴瘤放化疗中的保护作用。
Purpose To assess the safety and efficacy of neoadjuvant bevacizumab with standard chemoradiotherapy in locally advanced rectal cancer and explore biomarkers for response.
目的：评估在局部进展期直肠癌患者中联合贝伐单抗和标准放化疗的新辅助治疗有效性和安全性，并探索标志物反应。
After resection of pancreatic ductal carcinoma, 541 patients were randomized to one of four treatment groups: chemoradiotherapy, chemotherapy, both treatments, or observation only.
在胰导管癌切除术后，541名患者被随机分为4个治疗组：化放疗组、化疗组、化放疗与化疗联合应用组和单纯观察组。
Results Extended radical resection, neoadjuvant chemotherapy, orthotopic liver transplantation, photodynamic therapy and molecular chemoradiotherapy might improve the survival rate.
结果扩大根治切除、新辅助放疗化疗、原位肝移植、光动力学治疗和分子放化疗均能有效地提高患者的生存率。
While this report from the European Study Group for Pancreatic Cancer showed a survival benefit with adjuvant chemotherapy, there was no such benefit for adjuvant chemoradiotherapy.
来自于胰腺癌欧洲研究小组的这篇报导发现：采用辅助性化疗有利于延长存活期，而采用辅助性的化放疗却达不到同样的效果。
With more and more application of chemotherapeutic agents and new compatibility regimen, individualized preoperative chemoradiotherapy will further improve therapeutic efficacy of rectal cancer.
随着更多有效的药物及新配伍方案的引入，对直肠癌患者采取个体化的术前放化疗，将使直肠癌的治疗效果得到进一步提高。
Results Concurrent chemoradiotherapy in patients with the experimental group have the low incidence of respiratory fungal infections with improved quality of life, reduced hospitalization costs.
结果同期放化疗过程中治疗组患者呼吸道真菌感染发生率低，生活质量提高，住院费用减少。
Conclusions: pancreatic cancer cells resistance to chemoradiotherapy can induce epithelial-mesenchymal transition (EMT), and EMT may be related to resistance of chemoradiotherapy of pancreatic cancer.
结论：放、化疗抵抗的人胰腺癌细胞发生EMT，其与胰腺癌治疗抵抗有关。
Conclusions: pancreatic cancer cells resistance to chemoradiotherapy can induce epithelial-mesenchymal transition (EMT), and EMT may be related to resistance of chemoradiotherapy of pancreatic cancer.
结论：放、化疗抵抗的人胰腺癌细胞发生EMT，其与胰腺癌治疗抵抗有关。
应用推荐